Vitilgo remains a common yet complex challenge. Here, international leader and renowned expert, Dr Viktoria Eleftheriadou shares her hopes for the future of those navigating this condition.
Vitiligo is recognised as the most prevalent pigmentary disorder, and you can read more about it in my previous posts here. It transcends the boundaries of age, impacting around 50% of those who develop it before they reach the age of 20. Because of this, its characteristic depigmented patches can lead to emotional distress. So much so, figures suggests that one in six of those with vitiligo require antidepressants and/or anxiolytics within the first year following their diagnosis.
Historically, the condition has been overshadowed by limited research. However, I'm delighted that this narrative is undergoing a significant transformation. In fact, in recent years a surge of interest and commitment to understanding and treatment has emerged.
Pioneering Research: Late Phase Clinical Trials
The landscape of vitiligo research is evolving, and late-phase clinical trials are now underway globally. These trials represent a crucial turning point in our quest for effective treatments. Notably, the upcoming weeks mark a ground-breaking moment as these trials open for recruitment in the UK for the first time.
As the director of a specialised vitiligo clinic for both children and adults, I am at the forefront of connecting patients across the country to these promising opportunities. Collaborating with Walsall Manor and New Cross Hospitals, we are committed to advancing not only our understanding but also the treatment options available.
Empowering Patients: Hand-Held Phototherapy
One remarkable stride in vitiligo management is the integration of home hand-held phototherapy. Supported by evidence from clinical trials, this approach has demonstrated efficacy comparable to Excimer Laser treatments. What makes it even more promising is the convenience it brings - patients can undergo phototherapy in the comfort of their own homes following appropriate training.
Our commitment extends to providing home hand-held phototherapy services, ensuring accessibility for those seeking effective treatment. This modality can be seamlessly combined with topical treatments such as tacrolimus, topical corticosteroids, or oral antioxidants like V SOD.
Supplementing Treatment For Vitiligo
In a small clinical trial, V SOD capsules, containing Superoxide Dismutase (SOD), showcased their ability to induce re-pigmentation faster and more effectively. The promise lies in their ability to complement other treatments, opening new avenues for comprehensive management.
It is important to point out that you should consult a dermatologist like myself before starting any of the treatments discussed in this article. We will be able to suggest if its appropriate, and balance the risks and benefits. Whether you're considering participation in clinical trials or seeking innovative treatments, know that the landscape of vitiligo care is evolving, and your journey toward re-pigmentation and wellbeing is my shared mission.
To book a consultation with Dr Viktoria Eleftheriadou at Chamberlain Clinic please contact info@chamberlainclinic.co.uk or call 0121 455 9496 for more details.